CMS Approves Coverage for PQ Bypass TORUS 2 IDE Trial – Endovascular Today
December 19, 2019—PQ Bypass Inc. announced it has received approval for coverage from the Centers for Medicare and Medicaid Services (CMS) for t
December 19, 2019—PQ Bypass Inc. announced it has received approval for coverage from the Centers for Medicare and Medicaid Services (CMS) for t
In a large, real-world analysis of United States Medicare fee-for-service patients, Ferro et al found that inferior vena cava filter (IVC) use decline
February 4, 2025—Akura Medical, Inc., a privately held portfolio company of Shifamed LLC that is developing treatments for venous thromboembolis
February 3, 2025—Surmodics, Inc. announced the early clinical use of its Pounce XL thrombectomy system, which is currently in limited market rel
Alan Lumsden, MD Walter W. Fondren III Presidential Distinguished Chair, DeBakey Heart & Vascular Center Chair, Department of Cardiovascular S
February 3, 2025—Cagent Vascular, Inc. announced the launch of its Serranator SL-Pro percutaneous transluminal angioplasty (PTA) serration ballo
The VIVA Foundation, in collaboration with representatives from the American Venous Forum (AVF) and American Vein and Lymphatic Society (AVLS), publis
January 30, 2025—Viz.ai announced an expanded partnership with Softek Illuminate, Inc. The company stated that the partnership seeks to enable h
January 31, 2025—Penumbra recently announced the launch of the Lightning Bolt 12 and the Lightning Bolt 6X with Trax systems, the next generatio
January 31, 2025—In a multicenter, retrospective review of patients admitted with intact and ruptured abdominal aortic aneurysms (AAAs), thoraci
Recommendations for anti-thrombotic and anti-inflammatory regimens after deep venous disease interventions based on patient presentation, comorbidities, and type of intervention.